STOCK TITAN

Vanguard disaggregates holdings; Vanguard (NYSE: STE) reports 0 shares

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

STERIS PLC Schedule 13G/A amendment shows The Vanguard Group reports 0 shares beneficially owned, representing 0% of common stock after an internal realignment on January 12, 2026. The filing explains certain Vanguard subsidiaries will report ownership separately in reliance on SEC Release No. 34-39538.

Positive

  • None.

Negative

  • None.

Insights

Vanguard disaggregated holdings; reported position reduced to zero.

The amendment states The Vanguard Group underwent an internal realignment effective January 12, 2026, after which subsidiaries or divisions will report beneficial ownership separately under SEC Release No. 34-39538. The filing lists 0 shares beneficially owned and 0% ownership.

Cash-flow treatment or trading intentions are not disclosed; subsequent filings by the named subsidiaries may show where prior holdings are now reported.






G8473T100

(CUSIP Number)
03/13/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/27/2026

FAQ

What does The Vanguard Group's Schedule 13G/A say about its holdings in STERIS PLC (STE)?

The filing states The Vanguard Group beneficially owns 0 shares, or 0%, of STERIS PLC common stock. The change follows an internal realignment and reliance on SEC Release No. 34-39538 to report holdings separately by subsidiaries.

Why does the Schedule 13G/A report zero shares for Vanguard after the January 12, 2026 realignment?

Vanguard explains certain subsidiaries/divisions now report beneficial ownership separately under SEC Release No. 34-39538. As a result, The Vanguard Group no longer reports beneficial ownership of securities held by those subsidiaries, leading to the 0 share filing.

Does the amendment identify which Vanguard subsidiaries now report STERIS PLC shares?

The amendment does not list specific subsidiary names. It states subsidiaries or business divisions will report separately and pursue the same investment strategies; names and amounts will appear in the subsidiaries' respective filings if applicable.

Who signed the Schedule 13G/A amendment for Vanguard and when was it signed?

The amendment is signed by Ashley Grim, Head of Global Fund Administration, and is dated 03/27/2026. The signature attests to the filing's content regarding Vanguard's reported beneficial ownership.

Does this filing indicate Vanguard sold STERIS PLC shares or that STERIS ownership changed?

The filing does not state any sales or transfers by Vanguard; it attributes the reporting change to internal reorganization and disaggregation under SEC guidance. Transaction details or trading activity are not provided in this amendment.
Steris Plc

NYSE:STE

View STE Stock Overview

STE Rankings

STE Latest News

STE Latest SEC Filings

STE Stock Data

21.91B
97.76M
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
DUBLIN